Accepted Abstracts

Accepted Abstracts

See the research works accepted for presentation at CannX Tel Aviv 2022 and their allocation per categories. 

ID 112
SCI: Innovations in Science and Medicine

CANNABIDIOL DOWNREGULATES THE EXPRESSION OF THE HUMAN FAM111B GENE IN LUNG ADENOCARCINOMA

A. Arowolo1, M. Malebana1, F. Sunda1, C. Rhoda1
1University of Cape Town, Medicine (division Of Dermatology), Cape Town, South Africa

ID 79
SCI: Innovations in Science and Medicine

MEDICAL CANNABIS SIGNIFICANTLY DECREASES AVERAGE PAIN SCORE FOLLOWING ONLY THREE MONTHS OF USE

R. Duda1, A. Garibaldi2, K. Mahabir2, C. Smith2, C. Vannabouathong2

1BIDMC/HMS, Surgical Oncology, Boston, United States of America
2Skylight Health Group, Research, Ontario, Canada

ID 23
SCI: Innovations in Science and Medicine

NOVEL CANNABIDIOL (CBD)-INFUSED ABSORBABLE IMPLANT DELIVERY SYSTEM FOR NEUROTRAUMA

L. Friedman1, R. Zeman1

1New York Medical College, Cell Biology And Anatomy, Valhalla, United States of America

ID 69
SCI: Innovations in Science and Medicine

CANNABINOIDS AND CANNABIS EXTRACTS AFFECT METABOLIC SYNDROME PARAMETERS INCLUDING MICROBIOME IN MICE FED HIGH FAT-CHOLESTEROL DIET

J. Gorelick1, N. Bernstein2, Z. Madar3

1Merkaz Yehudah, Eastern Regional Research And Development Center, Kiryat Arba, Israel
2Volcani Institute, Institute Of Soil, Water And Environmental Sciences, Rishon LeZion, Israel
3The Hebrew University of Jerusalem,, The Robert H Smith Faculty Of Agriculture, Food And Environment,, Rehovot, Israel

ID 30
SCI: Innovations in Science and Medicine

METABOLIC EFFECTS OF MEDICAL CANNABIS TREATMENT

G. Habib1, S. Aamar2

1Laniado Hospital and Nazareth Hospital, Rheumatology Unit, Netanya & Nazareth, Israel
2Hadassah Mount Scopus-Hebrew University Medical School, Jerusalem,, Rheumatology Unit, Jerusalem, Israel

ID 139
SCI: Innovations in Science and Medicine

OBJECTIVE QUANTIFICATION OF THE IMPACT OF MEDICAL CANNABIS TREATMENT USING CANNABIS-RESPONSIVE BIOMARKERS

B. Goldstein1I. Kurek2

1Canna-Centers Wellness & Education, Medical, Rolling Hills Est, United States of America
2Cannformatics, Science, San Francisco, United States of America

ID 56
SCI: Innovations in Science and Medicine

PRE-CLINICAL TOXICITY OF CANNBIGEROL IN RATS AND C. ELEGANS

T. Lefever1, K. Trexler1, M. Toth2, L. Macnair1, S. Vanapalli2, S. Gupta2, M. Rahman2M. Bonn-Miller3

1Canopy Growth, Pre-clinical & Safety, Ontario, Canada
2NemaLife Inc., N/a, Lubbock, United States of America
3Canopy Growth, Human & Animal Research, Smiths Falls, Canada

ID 137
Innovations in Science and Medicine

CANNABIS USE IN GASTROINTESTINAL DISORDERS

M. Neuman1, L. Cohen2S. Malnick3

1In Vitro Drug Safety and Biotechnology, Pharmacology And Toxicology, University Of Toronto, Toronto, Canada
2Sunnybrook HSC, Gastroenterology, Ontario, Canada
3Kaplan Medical Center, Rehovot, Affiliated to Hebrew University, Internal Medicine C, Jerusalem, Israel

ID 72
Innovations in Science and Medicine

ADDRESSING THE OPIOID EPIDEMIC WITH RESEARCH AND REAL-WORLD DATA-INFORMED APPROACHES.

M. McNabb1, D. Berman2, D. Ritter1, M. Ogen2, S. White3

1Cannabis Center of Excellence, Inc, Research Department, Boston, United States of America
2CannabisBPO, Executive, Americus, United States of America
3UMass Dartmouth, Charlton College Of Business, Dartmouth, United States of America

ID 38
SCI: Innovations in Science and Medicine

CANNABIS IN MIGRAINE

L. Mechtler

DENT Neurologic Institute/NeuroNet Pro/American Society Of Neuroimaging, Neurology/neuro-oncology/cannabis, Buffalo, United States of America

ID 93
SCI: Innovations in Science and Medicine

POSSIBLE MODULATION OF THE NEURO-ENDOCRINE-CYTOKINE NETWORK BY THE PINEAL HORMONE MELATONIN AND CANNABIDIOL IN PSYCHOLOGY

G. Messina, P. Lissoni

International Institute of Pnei, Psycho-oncology, Milan, Italy

ID 74
SCI: Innovations in Science and Medicine

FEMALES REPORT MORE ADVERSE EVENTS AND HIGHER NEGATIVE SUBJECTIVE EFFECTS IN MULTIPLE-DOSE TRIALS OF TWO ORAL MEDICAL CANNABIS PRODUCTS

L. Macnair1E. Peters1, G. Eglit1, I. Mosesova1, M. Ware2, C. Turcotte1, M. Bonn-Miller1

1Canopy Growth Corporation, Human And Animal Research Program, Smiths Falls, Canada
2Canopy Growth, Office Of The Chief Medical Officer, Smiths Falls, Canada

ID 66
SCI: Innovations in Science and Medicine

EFFECT OF A CANNABIS EXTRACT ON ACUTE PAIN AND ON ANALGESICS REQUIREMENTS: A DOUBLE-BLINDED, RANDOMIZED, 24 HOURS FOLLOW-UP STUDY

E. Davidson1, A. Eyal2N. Raz2

1Hadassah Hebrew University Hospital, Department Of Anesthesiology, Ccm And Pain Relief, Jerusalem, Israel
2Bazelet Medical Cannabis Group, R&d, Or Akiva, Israel

ID 52
SCI: Innovations in Science and Medicine

THE CHEMOTYPES I AND III OF CANNABIS SATIVA L INDUCE DISTINCT TYPES OF CELL DEATH (APOPTOSIS / NECROSIS) IN HUMAN LEUKEMIC CELL LINES

S. Santander Gonzalez1, M. Rodríguez1, L. Contreras1, M. Pombo2, A. Mejia2, G. Modesti3

1Phyto Immunomodulation group. University Foundation Juan N Corpas, Medical School,, Bogotá, Colombia
2Group of Plant Pharmacology and Alternative Therapeutics, University Foundation Juan N Corpas, Medical School, Bogotá, Colombia
3Phytochemical research group. Pontificia University Javeriana., Chemistry, Bogotá, Colombia

ID 49
SCI: Innovations in Science and Medicine

ADHERENCE, SAFETY AND EFFECTIVENESS OF MEDICAL CANNABIS AND EPIDEMIOLOGICAL CHARACTERISTICS OF THE PATIENT POPULATION: A PROSPECTIVE STUDY

L. Schleider1, R. Mechoulam2, I. Sikorin3, T. Naftali4, V. Novack1

1Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Clinical Research Center, Be’er-Sheva, Israel
2The Hebrew University of Jerusalem, School Of Pharmacy, Jerusalem, Israel
3Tikun‑Olam Cannbit Pharmaceuticals, Research Department, Tel-Aviv, Israel
4Meir Medical Center, Department Of Gastroenterology And Hepatology, Kfar Saba, Israel

ID 146
SCI: Innovations in Science and Medicine

DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY OF CANNABIDIOL CONTAINING FACIAL SERUMS

E. Tavčar, N. Kugonič, S. Kreft

University of Ljubljana, Faculty Of Pharmacy, Ljubljana, Slovenia

ID 95
SCI: Innovations in Science and Medicine

VAPORISED MEDICAL GRADE CANNABINOIDS AS RESCUE MEDICATION IN ACUTE ANXIETY – A VALIDATION AUDIT OF ADULTS PATIENTS IN AN URGENT CARE DEPARTMENT

G. Xantus

University of Pécs, Emergency Department, Pécs, Hungary

ID 113
SCI: Innovations in Science and Medicine

HARNESSING CANNABIS MOLECULES TO FIGHT INFLAMMATION-ASSOCIATED DEPRESSION

R. Yirmiya, H. Goldenberg, E. Robinson, E. Dinur, L. Naggan, H. Verdiger, E. Kozela

The Hebrew University of Jerusalem, Psychology, Jerusalem, Israel

ID 134
BIZ: New Technologies, New Opportunities

EVIDENCE-BASED CUSTOMER DISCOVERY AS A FIRST STEP FOR DEVELOPING A DECENTRALIZED CLINICAL RESEARCH PLATFORM FOR MEDICAL CANNABIS

C. Fitzer-Attas1, S. Joshi2, C. Pascal3

1ClinMed LLC, Clinical Research & Medical Affairs, Dayton, United States of America
2Rutgers University, Biomedical Engineering, New Brunswick, United States of America
3Rutgers University, Library And Information Science, New Brunswick, United States of America

ID 77
BIZ: New Technologies, New Opportunities

WHY PORTUGAL MAY BE THE IDEAL HUB FOR MEDICAL CANNABIS IN EUROPE?

F. Frazão Aguiar

WISE HS, Medical Cannabis, Porto, Portugal

ID 140
BIZ: New Technologies, New Opportunities

A NOVEL EDUCATIONAL TOOL FOR DISPENSARY STAFF AND PATIENTS: MEDICAL CANNABIS EDUCATION APP

R. Galamaga1, M. Mitra2, K. Reeder3, J. Harp4, D. Hall4

1Caduceus Medical Consulting, Medicine, Chicago, United States of America
2University of Maryland, Natural Sciences, princess ann, United States of America
3Cannatracker, Education, Rockville, United States of America
4University of Maryland, Pharmacy, Rockville, United States of America

ID 57
BIZ: New Technologies, New Opportunities

CONTROLLED AND RAPID DRYING OF MEDICAL CANNABIS INFLORESCENCES BY RADIO FREQUENCY METHOD

A. Uziel1L. Milay2, S. Procaccia1, R. Cohen3, A. Burstein3, D. Lewitus4, D. Meiri1

1
Technion Israel Institute of Technology, Biology, Haifa, Israel

2CannaSoul Analytics, Projects, Caesarea, Israel
3Goji, Research, Kfar saba, Israel
4Shenkar – Engineering Art Design, Department Of Polymers And Plastics Engineering, Ramat-Gan, Israel

ID 84
AGR: Advanced Agriculture and Production

PRODUCTIVITY EFFECTS OF THREE SINGLE PLANT GROWTH PROMOTING RHIZOBACTERIA INOCULATION ON CANNABIS SATIVA L. GROWTH AND FLOWER YIELD AND CANNABINOIDS PROFILE

D. Lyu, R. Backer, D. Smith

McGill University, Plant Science, SAINTE-ANNE-DE-BELLEVUE, Canada

ID 64
AGR: Advanced Agriculture and Production

VEGETATIVE PROPAGATION EXPERIMENTS ON MEDICINAL CANNABIS (CANNABIS SATIVA L.)

S. Moerenhout1, M. Holweg2

1Cultivators, Managing Partner, Etten-Leur, Netherlands, 2Cultivators, Research, Etten-Leur, Netherlands

ID 105
AGR: Advanced Agriculture and Production

UTILIZATION OF BENEFICIAL AND HIGHLY-EFFICACIOUS PHYTOMICROBIOME TECHNOLOGIES EFFECTS IN PRODUCTION OF CANNABIS SATIVA

D. Smith

McGill University, Plant Science, SAINTE-ANNE-DE-BELLEVUE, Canada

ID 50
SCI: Innovations in Science and Medicine

NITROGEN CONTAINING CANNABINOLIC ACIDS DERIVATIVES AS A NEW ANTICANCER DRUGS

A. Aizikovich

AL&AM Pharmachem Ltd, Cannabinoid Medicinal Chemistry, Rehovot, Israel

ID 96
SCI: Innovations in Science and Medicine

CANNABIS PRODUCTS IN POORLY REGULATED MARKETS: PUBLIC HEALTH, ETHICS, AND MESSAGING

A. Budney, J. Borodovsky

Dartmouth College, Geisel School Of Medicine, Lebanon, United States of America

ID 83
SCI: Innovations in Science and Medicine

THERAPEUTIC DRUG MONITORING OF CANNABIDIOL AND IMMUNOSUPPRESSANTS IN A KIDNEY TRANSPLANT PATIENT. CASE REPORT

L. Cuñetti1, C. Maldonado2, M. Vázquez2, L. Manzo1, R. Peyraube3

1Instituto de Nefrología y Urología, Unidad De Trasplante Renal, Montevideo, Uruguay
2Facultad de Química UDELAR, Departamento De Ciencias Farmacéuticas, Montevideo, Uruguay
3Universidad Nacional de Rosario, Centro De Estudios Interdisciplinarios, Rosario, Argentina

ID 62
SCI: Innovations in Science and Medicine

MEDICAL CANNABIS AND QUALITY OF LIFE IN PEOPLE LIVING WITH HIV

F. De Aguiar1, P. Costa2, F. Neves3, V. Duque4

1Fundação Portuguesa A Comunidade Contra a SIDA, Psychology, Lisboa, Portugal
2Fundação Portuguesa A Comunidade Contra a SIDA, Research, Lisboa, Portugal
3Centro Hospitalar do Porto – Centro Materno Infantil, Anestesiologia, Porto, Portugal
4Centro Hospitalar e Universitário de Coimbra, Infeciologia, Coimbra, Portugal

ID 130
SCI: Innovations in Science and Medicine

HUMAN MILK FEEDING AND CANNABIS USE : RECOMMENDATIONS FROM THE FIELD POST CANNABIS LEGALIZATION IN VERMONT

J. Dolan

CannaMommy Non-profit, Director, Underhill, VT, United States of America

ID 31
SCI: Innovations in Science and Medicine

INHIBITION OF HEPATOCELLULAR CARCINOMA GROWTH AND LIVER FIBROSIS BY NANOMOLAR CANABINOID CONCENTRATIONS

I. Itzhak, F. Barer, P. Fishman

Can-Fite BioPharma, Molecular Biology Labs, Petach-Tikva, Israel

ID 59
SCI: Innovations in Science and Medicine

CANNABIS STRAINS AND CANNABINOIDS PLAY KEY ROLE IN MODULATION OF NEUROINFLAMMATION

S. Fleisher-Berkovich1, Y. Ventura1, V. Feinshtein1, N. Bernstein2, J. Gorelick3, S. Ben-Shabat1

1Ben-Gurion University of the Negev, Clinical Biochemistry And Pharmacology, Beer-Sheva, Israel
2Volcani Center, Institute Of Soil, Water And Environmental Sciences, Rishon Lezion, Israel
3Judea center, Eastern Regional Research And Development Center, Kiryat Arba, Israel

ID 71
SCI: Innovations in Science and Medicine

INHALED CBD PHARMACOKINETIC PROFILE IN RATS

K. Trexler1, J. Macdonald2, D. Schwotzer2M. Bonn-Miller3, M. Ware4, T. Lefever1

1Canopy Growth, Pre-clinical & Safety, Ontario, Canada
2Lovelace Biomedical, Life Sciences, Albuquerque, United States of America
3Canopy Growth, Human & Animal Research, Smiths Falls, Canada
4Canopy Growth, Office Of The Chief Medical Officer, Smiths Falls, Canada

ID 53
SCI: Innovations in Science and Medicine

CANNABIDIOL REDUCES EXTRACELLULAR LEVELS OF GLUTAMATE IN HIPPOCAMPUS OF RATS WITH TEMPORAL LOBE EPILEPSY

C. Martínez-Aguirre1, C. Santiago-Castañeda1, M. Cuéllar-Herrera2, L. Rocha-Arrieta1

1Center for research and advanced studies, Pharmacobiology, Ciudad de Mexico, Mexico
2Hospital General de México Dr. Eduardo Liceaga, Epilepsy Clinic, Ciudad de Mexico, Mexico

ID 26
SCI: Innovations in Science and Medicine

MEDICAL CANNABIS IN THE ELDERLY POPULATION

L. Mechtler1, M. Caserta2

1DENT Neurologic Institute/NeuroNet Pro/American Society Of Neuroimaging, Neurology/neuro-oncology/cannabis, Buffalo, United States of America
2DENT Neurologic Institute, Neurology/neuro-oncology/cannabis, Buffalo, United States of America

ID 34
SCI: Innovations in Science and Medicine

CAROTENOIDS AND CANNABINOIDS: AN INNOVATIVE ANTI-INFLAMMATORY COMBINATION

T. Offer1, Y. Solomonov1, R. Levy2

1Lycored, Global R&d, Beer Sheva, Israel
2BGU, Clinical Biochemistry, Beer Sheva, Israel

ID 33
SCI: Innovations in Science and Medicine

MEDICAL CANNABIS IN THE TREATMENT OF NEUROPATHY

C. Ralyea1, L. Mechtler2

1Dent Neurologic Institute, Cannabis Research Center, Amherst, United States of America
2DENT Neurologic Institute/NeuroNet Pro/American Society Of Neuroimaging, Neurology/neuro-oncology/cannabis, Buffalo, United States of America

ID 65
SCI: Innovations in Science and Medicine

OPTIMAL TREATMENT WITH CANNABIS OILS VIA ENRICHMENT WITH SPECIFICALLY SELECTED MONOTERPENES AND MONOTERPENOIDS

N. Raz1, A. Eyal1, D. Berneman Zeitouni1, E. Davidson2

1Bazelet Medical Cannabis Group, R&d, Or Akiva, Israel
2Hadassah Hebrew University Hospital, Department Of Anesthesiology, Ccm And Pain Relief, Jerusalem, Israel

ID 55
SCI: Innovations in Science and Medicine

CANNABIDIOL PRETREATMENT AVOIDS THE SHORT- AND LONG-TERM HIGH EXTRACELLULAR RELEASE OF GLUTAMATE SUBSEQUENT TO A SEVERE TRAUMATIC BRAIN INJURY

C.L. Santiago-Castañeda1, S. Huerta De La Cruz1, C. Martínez-Aguirre1, S.A. Orozco-Suarez2, L. Rocha-Arrieta1

1Center for Research and Advanced Studies (CINVESTAV), Pharmacobiology, Ciudad de Mexico, Mexico
2Specialties Hospital, National Medical Center SXXI (CMN-SXXI), Unit For Medical Research Neurological Diseases, Mexico, Mexico

ID 61
SCI: Innovations in Science and Medicine

NON-SYNCHRONOUS EVAPORATION OF CANNABIS’ ACTIVE INGREDIENTS – POTENTIAL IMPLICATIONS FOR SMOKING AND VAPING THE MEDICAL CANNABIS DRUG

D. Schlesinger, N. Raz, D. Berneman Zeitouni, D. Tal, A. Eyal

Bazelet Medical Cannabis Group, R&d, Or Akiva, Israel

ID 45
SCI: Innovations in Science and Medicine

CYTOTOXIC ACTIVITY OF Δ9–TETRAHYDROCANNABINOL (THC)-RICH COMPOSITIONS FROM CANNABIS AGAINST OVARIAN CANCER CELLS AND THEIR SYNERGY WITH NIRAPARIB.

N. Shalev1,2, H. Koltai2

1ARO- Volcani center, Plant Science, Rishon LeZion, Israel
2ARO-Volcani center, Plant Science, Rishon LeZion, Israel

ID 141
SCI: Innovations in Science and Medicine

TRISSOMY 21 AND LENNOX-GASTAUT SYNDROME: A REPORT OF IMPROVEMENT AFTER CANABIDIOL USE

R. Wajnsztejn1,2, R. Anghinah2

1University of ABC, Neurology, São Bernardo do Campo – SP, Brazil
2University of Sao Paulo, Neurology, São Bernardo do Campo, Brazil

ID 25
SCI: Innovations in Science and Medicine

EFFICIENT NEBULIZABLE CANNABINOID CARRYING CONTROLLED RELEASE SUSPENSIONS AND FORMULATIONS.

J. Wyse1, L. Lurya2

1Bressler IP, Patents, Ramat Gan, Israel
2Dr. Lurya Ltd, R&d, Jerusalem, Israel

ID 76
BIZ: New Technologies, New Opportunities

TRANSFORMING ACADEMIC EDUCATION AND RESEARCH AROUND CANNABIS LEGALIZATION, MEDICAL-USE CANNABIS, AND SOCIAL EQUITY IN NEW JERSEY

M. Mcnabb1, D. Ritter1, D. Berman2M. Ogen2, S. Trocchio3, S. Scott4

1Cannabis Center of Excellence, Inc, Research Department, Boston, United States of America
2CannabisBPO, Executive, Americus, United States of America
3Rider University, Criminal Justice, Lawrenceville, United States of America
4Self, Senior Cannabis Consultant, Philadelphia, United States of America

ID 104
AGR: Advanced Agriculture and Production

CAN CARBON DOTS INCREASE SECOND METABOLITES LEVELS IN CANNABIS? A SOLID HYPOTHESIS.

P. Fortes1, S. Tinman2, N. Neto3S. Beguerie4

1UFPI, Business, Teresina, Brazil
2Cannapi, Ceo, Sao Paulo, Brazil
3IESVAP, Medicine, Parnaíba, Brazil
4Alpha-CAT, Ceo, Prague, Czech Republic

ID 47
AGR: Advanced Agriculture and Production

PREDICTION OF PHYTOCANNABINOID AND TERPENE CONCENTRATIONS IN CANNABIS INFLORESCENCE USING NEAR-INFRARED SPECTROSCOPY AND CHEMOMETRICS

M. Birenboim1, D. Chalupowicz2, Y. Chen2, E. Falik2, D. Kengisbuch2, J. Shimshoni2

1The Robert H Smith Faculty of Agriculture, Food and Environment, Rehovot, Plant Science, Rehovot, Israel
2Volcani center, Institute For Postharvest And Food Sciences, rishon lezion, Israel

ID 70
AGR: Advanced Agriculture and Production

ANALYSIS OF MAIN ACTIVE SUBSTANCES IN DIFFERENT HEMP (CANNABIS SATIVA L.) PHENOTYPES

A. Čerenak1, M. Eržen1, I.J. Košir1, M. Ocvirk2, K. Rutnik2, S. Kreft3

1Slovenian Institute of Hop Research and Brewing, Department For Plants, Soil And Environment, Žalec, Slovenia
2Slovenian Institute of Hop Research and Brewing, Department For Agrochemistry And Brewing, Žalec, Slovenia
3University of Ljubljana, Faculty Of Pharmacy, Ljubljana, Slovenia

ID 102
AGR: Advanced Agriculture and Production

PAVING THE ROAD TO CANNABIS/HEMP STANDARDIZATION: MODERN AND NEW BREEDING TECHNOLOGIES (NBT’S) ACCELERATING CANNABIS VARIETY DEVELOPMENT AND EFFICIENT CULTIVATION

T. Sherman

BETTERSEEDS, R&d, Givat Hen, Israel

AGR: Advanced Agriculture and Production

RESPONSE OF MEDICAL CANNABIS PLANTS TO NITROGEN (N) SUPPLY

A. Saloner, N. Bernstein

Institute of Soil, Water and Environmental Sciences, Volcani Center, Rishon LeZion, Israel

AGR: Advanced Agriculture and Production

EFFECTS OF MAGNESIUM (MG) SUPPLY ON MEDICAL CANNABIS PLANTS

D. Morad, N. Bernstein

Institute of Soil, Water and Environmental Sciences, Volcani Center, Rishon LeZion, Israel

Print Friendly, PDF & Email